Clinical trial
Stem Cell Transplant for Inborn Errors of Metabolism
NCT00176904 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00176904 |
|---|---|
| Title | Stem Cell Transplant for Inborn Errors of Metabolism |
| Official title | Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Bone Marrow Transplantation |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy, Gaucher's Disease, Fucosidosis, Wolman Disease, Niemann-Pick Disease, Batten Disease, GM1 Gangliosidosis, Tay Sachs Disease and 1 more |
| Intervention type | Drug, Procedure |
| Interventions | Stem Cell Transplant, Busulfan, Cyclophosphamide, Antithymocyte Globulin |
| Enrollment | 135 |
| Start date | Jan 1, 1995 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: